Manulife (Manufacturers Life Insurance)’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-869
| Closed | -$25.9K | – | 3092 |
|
|
2022
Q1 | $25.9K | Sell |
869
-473
| -35% | -$14.1K | ﹤0.01% | 3058 |
|
|
2021
Q4 | $58 | Buy |
1,342
+350
| +35% | +$15 | ﹤0.01% | 3087 |
|
|
2021
Q3 | $71K | Sell |
992
-1,170
| -54% | -$83.7K | ﹤0.01% | 3119 |
|
|
2021
Q2 | $248K | Buy |
2,162
+78
| +4% | +$8.95K | ﹤0.01% | 2953 |
|
|
2021
Q1 | $216K | Sell |
2,084
-144
| -6% | -$14.9K | ﹤0.01% | 2839 |
|
|
2020
Q4 | $107K | Buy |
2,228
+596
| +37% | +$28.6K | ﹤0.01% | 2947 |
|
|
2020
Q3 | $45K | Buy |
1,632
+241
| +17% | +$6.65K | ﹤0.01% | 2892 |
|
|
2020
Q2 | $90K | Buy |
+1,391
| New | +$90K | ﹤0.01% | 2778 |
|
|
2018
Q3 | – | Sell |
-61
| Closed | -$3K | – | 3572 |
|
|
2018
Q2 | $3K | Sell |
61
-168
| -73% | -$8.26K | ﹤0.01% | 4162 |
|
|
2018
Q1 | $10K | Buy |
229
+132
| +136% | +$5.76K | ﹤0.01% | 3921 |
|
|
2017
Q4 | $9K | Buy |
97
+2
| +2% | +$186 | ﹤0.01% | 4005 |
|
|
2017
Q3 | $14K | Sell |
95
-60
| -39% | -$8.84K | ﹤0.01% | 3748 |
|
|
2017
Q2 | $16K | Buy |
155
+100
| +182% | +$10.3K | ﹤0.01% | 3716 |
|
|
2017
Q1 | $6K | Hold |
55
| – | – | ﹤0.01% | 3749 |
|
|
2016
Q4 | $7K | Sell |
55
-40
| -42% | -$5.09K | ﹤0.01% | 3857 |
|
|
2016
Q3 | $9K | Hold |
95
| – | – | ﹤0.01% | 3720 |
|
|
2016
Q2 | $7K | Sell |
95
-93
| -49% | -$6.85K | ﹤0.01% | 3718 |
|
|
2016
Q1 | $18K | Buy |
+188
| New | +$18K | ﹤0.01% | 3504 |
|